本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aldeyra Therapeutics Inc

1.37
-0.0900-6.16%
盤後1.36-0.0100-0.73%19:30 EDT
成交量:83.36萬
成交額:114.69萬
市值:8,242.30萬
市盈率:-3.57
高:1.45
開:1.45
低:1.35
收:1.46
52周最高:5.93
52周最低:1.07
股本:6,016.28萬
流通股本:4,892.94萬
量比:0.92
換手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):-0.3836
每股收益(LYR):-0.5636
淨資產收益率:-49.48%
總資產收益率:-22.70%
市淨率:2.18
市盈率(LYR):-2.43

資料載入中...

2024/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/23

SEC問詢函

Form CORRESP - Correspondence
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals